Krishna BP, Reddy BP, Yashavanth Kumar DS, Ummar M, Shekhar V, Chandra Tiwari RV. Role of Serratiopeptidase and Dexamethasone in the Control of Postoperative Swelling. Ann Maxillofac Surg. 2020 Jan-Jun;10(1):108-113. doi: 10.4103/ams.ams_249_19. Epub 2020 Jun 8. PubMed PMID: 32855925; PubMed Central PMCID: PMC7433958.
Sahu S, Patley A, Kharsan V, Madan RS, Manjula V, Tiwari RVC. Comparative evaluation of efficacy and latency of twin mix vs 2% lignocaine HCL with 1:80000 epinephrine in surgical removal of impacted mandibular third molar. J Family Med Prim Care. 2020 Feb;9(2):904-908. doi: 10.4103/jfmpc.jfmpc_998_19. eCollection 2020 Feb. PubMed PMID: 32318443; PubMed Central PMCID: PMC7113948.
Sahu S, Patley A, Kharsan V, Madan RS, Manjula V, Tiwari RVC. Comparative evaluation of efficacy and latency of twin mix vs 2% lignocaine HCL with 1:80000 epinephrine in surgical removal of impacted mandibular third molar. J Family Med Prim Care. 2020 Feb;9(2):904-908. doi: 10.4103/jfmpc.jfmpc_998_19. eCollection 2020 Feb. PubMed PMID: 32318443; PubMed Central PMCID: PMC7113948.
EVALUATION AND RECENT TECHNIQUES OF TRANSDERMAL DRUG DELIVERY SYSTEM”.pptxRahulBGole
PRESENTATION OUTLINE
1.Introduction
2.Evaluation Of Transdermal Drug Delivery System
2.1 Physicochemical Evaluation
2.2 In Vitro Release Studies
2.3 In Vivo Evaluation
2.4 Cutaneous Toxicological Evaluation
3. Recent Techniques For Enhancing TDDS
3.1 Structure Based Enhancemnet Techniques
3.2 Electrically Based Enhancement Techniques
3.3 Velocity Based Enhancement Techniques
3.4 Other Enhancement Techniques
4. Conclusion
5. References
1.Introduction :Transdermal drug delivery systems (TDDS), also known as ''patches,'' are dosage forms designed to deliver a therapeutically effective amount of drug across a patient's skin.
2.Evaluation of Transdermal Drug Delivery System:
2.1Physicochemical Evaluation:
Physicochemical Evaluation
In Vitro Release Studies
In Vivo Evaluation
Cutaneous Toxicological Evaluation
2.2. In Vitro Release Studies
●The Paddle over Disc:
The transdermal system is attached to a disc or cell resting at the bottom of the vessel which contains medium at 32 ±5°C.
●The Cylinder modified USP Basket:
The system is attached to the surface of a hollow cylinder immersed in medium at 32 ±5°C.
●Franz diffusion cell:
The cell is composed of two compartments: donor and receptor. The receptor compartment has a volume of 5-12ml and effective surface area of 1-5 cm.The diffusion buffer is continuously stirred at 600rpm by a magnetic bar.
2.3. In Vivo Evaluation
●Animal models:
The most common animal species used for evaluating transdermal drug delivery system are mouse, hairless rat, hairless dog, hairless rhesus monkey, rabbit,guinea pig etc.
●Evaporative water loss management:
Content irritation also disrupts the stratum corenum barrier and causes and excessive water loss from the damaged surface that can be measured means of evaporimetry.
3. Recent Techniques for Enhancing TDDS
3.1. Structure-Based Enhancement Techniques
●Macroflux:
This technology offers a needle-free and painless transdermal drug delivery of large-molecular-weight compounds such as insulin,several peptidic hormones, and vaccines.
●Microfabricated Microneedles:
A transdermal patch or skin adhesive patch is that device which is loaded with drug candidate and usually applied on the skin to transport a specific dose of medication across the skin and into the blood circulation.
3.2.Electrically-Based Enhancement Techniques
●Ultrasound:
In this technique, there is a mixing of drug substance with a coupling agent (usually with gel, cream or ointment) that causes ultrasonic energy transfer from the system to the skin.
●Iontophoresis:
permeation of ionized drug through electrical impulses of 0.5 mA/cm by either galvanic or voltaic cell. It contains cathode and anode which attracts positively charged ion and negatively charged ions, respectively
3.3. Velocity Based Enhancement Techniques:
●Needle-Free Injections:
The liquid or solid particles are fired at supersonic speeds through the outer layers of the skin using a reliable energy source for delivering the drug.
Mahendra Azad et al. GAINT ODONTOGENIC KERATOCYST OF MANDIBLE OPERATED UNDER LOCAL ANESTHESIA- A CASE REPORT. JOURNAL OF DENTAL HEALTH & RESEARCH (VOL. 1, ISSUE 2, JUL - DEC 2020): 24-2
42.Shilpa Sunil Khanna et al. Efficacy of Tranexamic Acid on Intraoperative Blood Loss in third molar Surgery: A Split Mouth Randomized Study. J Res Adv Dent 2020;10:3:192-196.
The Use of Three Different Suturing Techniques for Wound Closure of Mucoperio...Ziad Hazim Delemi
The Use of Three Different Suturing Techniques for Wound Closure of Mucoperiosteal Flaps After Surgical Removal of Impacted Lower Wisdom Teeth (Comparative Study)
Effect of Surgery Difficulty According to Impaction Level on the Incidence of...iosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
International Journal of Pharmaceutical Science Invention (IJPSI)inventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
EVALUATION AND RECENT TECHNIQUES OF TRANSDERMAL DRUG DELIVERY SYSTEM”.pptxRahulBGole
PRESENTATION OUTLINE
1.Introduction
2.Evaluation Of Transdermal Drug Delivery System
2.1 Physicochemical Evaluation
2.2 In Vitro Release Studies
2.3 In Vivo Evaluation
2.4 Cutaneous Toxicological Evaluation
3. Recent Techniques For Enhancing TDDS
3.1 Structure Based Enhancemnet Techniques
3.2 Electrically Based Enhancement Techniques
3.3 Velocity Based Enhancement Techniques
3.4 Other Enhancement Techniques
4. Conclusion
5. References
1.Introduction :Transdermal drug delivery systems (TDDS), also known as ''patches,'' are dosage forms designed to deliver a therapeutically effective amount of drug across a patient's skin.
2.Evaluation of Transdermal Drug Delivery System:
2.1Physicochemical Evaluation:
Physicochemical Evaluation
In Vitro Release Studies
In Vivo Evaluation
Cutaneous Toxicological Evaluation
2.2. In Vitro Release Studies
●The Paddle over Disc:
The transdermal system is attached to a disc or cell resting at the bottom of the vessel which contains medium at 32 ±5°C.
●The Cylinder modified USP Basket:
The system is attached to the surface of a hollow cylinder immersed in medium at 32 ±5°C.
●Franz diffusion cell:
The cell is composed of two compartments: donor and receptor. The receptor compartment has a volume of 5-12ml and effective surface area of 1-5 cm.The diffusion buffer is continuously stirred at 600rpm by a magnetic bar.
2.3. In Vivo Evaluation
●Animal models:
The most common animal species used for evaluating transdermal drug delivery system are mouse, hairless rat, hairless dog, hairless rhesus monkey, rabbit,guinea pig etc.
●Evaporative water loss management:
Content irritation also disrupts the stratum corenum barrier and causes and excessive water loss from the damaged surface that can be measured means of evaporimetry.
3. Recent Techniques for Enhancing TDDS
3.1. Structure-Based Enhancement Techniques
●Macroflux:
This technology offers a needle-free and painless transdermal drug delivery of large-molecular-weight compounds such as insulin,several peptidic hormones, and vaccines.
●Microfabricated Microneedles:
A transdermal patch or skin adhesive patch is that device which is loaded with drug candidate and usually applied on the skin to transport a specific dose of medication across the skin and into the blood circulation.
3.2.Electrically-Based Enhancement Techniques
●Ultrasound:
In this technique, there is a mixing of drug substance with a coupling agent (usually with gel, cream or ointment) that causes ultrasonic energy transfer from the system to the skin.
●Iontophoresis:
permeation of ionized drug through electrical impulses of 0.5 mA/cm by either galvanic or voltaic cell. It contains cathode and anode which attracts positively charged ion and negatively charged ions, respectively
3.3. Velocity Based Enhancement Techniques:
●Needle-Free Injections:
The liquid or solid particles are fired at supersonic speeds through the outer layers of the skin using a reliable energy source for delivering the drug.
Mahendra Azad et al. GAINT ODONTOGENIC KERATOCYST OF MANDIBLE OPERATED UNDER LOCAL ANESTHESIA- A CASE REPORT. JOURNAL OF DENTAL HEALTH & RESEARCH (VOL. 1, ISSUE 2, JUL - DEC 2020): 24-2
42.Shilpa Sunil Khanna et al. Efficacy of Tranexamic Acid on Intraoperative Blood Loss in third molar Surgery: A Split Mouth Randomized Study. J Res Adv Dent 2020;10:3:192-196.
The Use of Three Different Suturing Techniques for Wound Closure of Mucoperio...Ziad Hazim Delemi
The Use of Three Different Suturing Techniques for Wound Closure of Mucoperiosteal Flaps After Surgical Removal of Impacted Lower Wisdom Teeth (Comparative Study)
Effect of Surgery Difficulty According to Impaction Level on the Incidence of...iosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
International Journal of Pharmaceutical Science Invention (IJPSI)inventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
60.Srinivasan S, Velusamy G, Munshi MAI, Radhakrishnan K, Tiwari RVC. Comparative Study of Antifungal Efficacy of Various Endodontic Irrigants with and without Clotrimazole in Extracted Teeth Inoculated with Candida albicans. J Contemp Dent Pract. 2020 Dec 1;21(12):1325-1330. PubMed PMID: 33893253.
Mathew P, Kattimani VS, Tiwari RV, Iqbal MS, Tabassum A, Syed KG. New Classification System for Cleft Alveolus: A Computed Tomography-based Appraisal. J Contemp Dent Pract. 2020 Aug 1;21(8):942-948. PubMed PMID: 33568619
65.Izna, Sasank Kuntamukkula VK, Khanna SS, Salokhe O, Chandra Tiwari RV, Tiwari H. Knowledge and Apprehension of Dental Health Professionals Pertaining to COVID in Southern India: A Questionnaire Study. J Pharm Bioallied Sci. 2021 Jun;13(Suppl 1):S448-S451. doi: 10.4103/jpbs.JPBS_551_20. Epub 2021 Jun 5. PubMed PMID: 34447131; PubMed Central PMCID: PMC8375944.
Vohra P, Belkhode V, Nimonkar S, Potdar S, Bhanot R, Izna, Tiwari RVC. Evaluation and diagnostic usefulness of saliva for detection of HIV antibodies: A cross-sectional study. J Family Med Prim Care. 2020 May;9(5):2437-2441. doi: 10.4103/jfmpc.jfmpc_138_20. eCollection 2020 May. PubMed PMID: 32754516; PubMed Central PMCID: PMC7380795
Mittal S, Hussain SA, Tiwari RVC, Poovathingal AB, Priya BP, Bhanot R, Tiwari H. Extensive pelvic and abdominal lymphadenopathy with hepatosplenomegaly treated with radiotherapy-A case report. J Family Med Prim Care. 2020 Feb;9(2):1215-1218. doi: 10.4103/jfmpc.jfmpc_1125_19. eCollection 2020 Feb. PubMed PMID: 32318498; PubMed Central PMCID: PMC7113973.
36.Kesharwani P, Hussain SA, Sharma N, Karpathak S, Bhanot R, Kothari S, Tiwari RVC. Massive radicular cyst involving multiple teeth in pediatric mandible- A case report. J Family Med Prim Care. 2020 Feb;9(2):1253-1256. doi: 10.4103/jfmpc.jfmpc_1059_19. eCollection 2020 Feb. PubMed PMID: 32318508; PubMed Central PMCID: PMC7113959.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
2. Krishna, et al.: Serratiopeptidase and dexamethasone in postoperative swelling
Annals of Maxillofacial Surgery ¦ Volume 10 ¦ Issue 1 ¦ January-June 2020 109
damaged area and phagocytize invading microorganisms
and debris. As a side effect of this process, there is an escape
of fluid into interstitial spaces resulting in edema. The
inflammatory process is necessary if healing is to occur, but
often excessive inflammation causes edema leading to pain
and trismus.[3]
Several types of medications such as antihistamines, enzymes,
and steroids have been used to inhibit these postoperative
sequelae. The principal effective physical method for relieving
edema is the use of drains, while all the pharmacological
agents tried, the anti‑inflammatory steroids appear to be
most successful and remain in common usage, even though
its immunosuppressive effects are well recognized in
medicine.[4]
The use of corticosteroids to control inflammation
following the third molar surgeries has been an area of
dispute. Newer synthetic analogs of corticosteroids, with
varying doses and different routes of administration, have
been investigated over the years.[5]
Dexamethasone is potent,
highly selective long‑acting, synthetic corticosteroids, which
has anti‑inflammatory action.[6]
Previous studies on the use
of dexamethasone to control postoperative edema have been
concluded with an emphasis that there is a great need for
well‑designed clinical research to further evaluate protocols for
corticosteroid use.[7]
Serratiopeptidase, a proteolytic enzyme,
decomposes bradykinin, thus producing anti‑inflammatory
action. Serratiopeptidase is promising from the knowledge
of pharmacology of the enzymes and the pathology of the
inflammatory edema. There is no sufficient evidence from the
investigations regarding its efficacy in reducing postoperative
edema, and hence, it can be investigated.[8]
The present study is designed to investigate, evaluate, and
compare the ability of serratiopeptidase and dexamethasone
to control edema following surgical removal of the mandibular
third molar.
Materials and Methods
The study was carried out on 100 patients, requiring surgical
extraction of mandibular third molars from October 2004
to September 2006. Patients were enrolled for the study
consecutively as and when they were presented. Selected
patients were allocated to the dexamethasone group and
serratiopeptidase group by randomization procedure,
irrespective of age and sex. The following were the criteria
for the selection of patients for the study.
Inclusion criteria
1. Bony impacted mandibular third molar
2. Routine blood and urine examination revealing no
abnormal values
3. The first and second molar on the side of surgery must be
present.
Exclusion criteria
1. The patients with systemic complications such as bleeding
disorders
2. Recent swelling or infection in the area of surgery
3. Patients who took proteolytic drugs or steroids 1 day
before surgery
4. Contraindication for the use of corticosteroids such as
diabetes mellitus, active tuberculosis, ocular herpes,
glaucoma, peptic ulceration, pregnancy, and hypertension.
Institutional ethical clearance was obtained for the study.
Following informed consent of the patient and preoperative
investigations, the patients were taken for surgery under
local anesthesia. Dexamethasone group was given 1 mg of
dexamethasone, one-half h before surgery and continued 1 mg,
8th
hourly for 3 days postoperatively. Serratiopeptidase group
was given 10 mg of serratiopeptidase, 8th
hourly for 3 days
postoperatively.
Preoperative measurements were taken by marking 7 points on
the face with indelible ink on the following facial landmarks:
mandibular angle, tragus, lateral canthus of the eye, alar base,
lip commissure, pogonion, and the midpoint of the hyoid bone.
With the mandibular angle as the base point and using 3‑0 silk
suture to follow the contour of the face, linear distances to the
other landmarks were noted. The sum of all measurements
was taken as the facial size. Cheek girth was measured by
measuring the maximum width of the soft tissues in the anterior
masseter region. It was measured in millimeters using calipers
by keeping one of the limbs of the calipers intraorally in the
embrasure between the first and second mandibular molars and
the other limb extraorally, so as to touch approximately 1 cm
above the anterior inferior border of the masseter [Figure 1].
Standard surgical techniques and protocols were followed for
surgical removal of the mandibular third molar. Amoxicillin,
500 mg and metronidazole, 400 mg were given orally,
8th
hourly for 5 days, for prophylactic antibiotic coverage
and diclofenac sodium 50 mg was given orally, 8th
hourly for
3 days for management of postoperative pain. Facial size and
cheek girth were measured on 1st
, 2nd
, 5th
, and 7th
postoperative
days in the same manner, as preoperative facial measurements
were recorded. The data were recorded for the statistical
analysis. Paired Student’s t‑test was applied for intragroup
comparison of facial measurement and cheek girth within the
dexamethasone group and serratiopeptidase group. Unpaired
Student’s t‑test was applied for intergroup comparison of facial
measurement and cheek girth between the dexamethasone
group and serratiopeptidase group.
Results
Theswellingwasrecordedonthe1st
,2nd
,5th
and7th
postoperative
days. The dexamethasone group consisted of 31 males and
19 females. The age range of the patients was 18–50 years with
a mean age of 25.8 ± 7.1. The serratiopeptidase group consisted
of 32 males and 18 females. The age ranges of the patients
were 17–65 years with a mean age of 27.2 ± 9.8. Table 1 shows
the changes in facial measurement in the serratiopeptidase
group. It shows the mean difference in facial measurement
on postoperative day 1, day 2, day 5, and day 7. There was
[Downloaded free from http://www.amsjournal.com on Monday, June 8, 2020, IP: 123.201.248.82]
3. Krishna, et al.: Serratiopeptidase and dexamethasone in postoperative swelling
Annals of Maxillofacial Surgery ¦ Volume 10 ¦ Issue 1 ¦ January-June 2020
110
highly significant reduction in facial measurement on the
postoperative day 5 in the serratiopeptidase group.
Table 2 shows changes in the facial measurement in the
dexamethasone group. It shows the mean difference in facial
measurement on postoperative day 1, day 2, day 5, and day 7.
There was highly significant reduction in facial measurement
on the postoperative day 2 in dexamethasone. Figure 2
shows mean comparative efficacies of serratiopeptidase and
dexamethasone in reducing facial swelling on postoperative
Figure 1: Cheek girth measurement
Figure 3: Graph showing cheek girth
day 1, day 2, day 5, and day 7. There was highly significant
difference in facial measurement between the serratiopeptidase
group and dexamethasone group on postoperative day 2
(mean difference was 62.5 with P < 0.001) and significant
difference on postoperative day 1, day 5, and day 7 (P < 0.01).
Table 3 shows changes in cheek girth in the serratiopeptidase
group. It shows the mean difference in cheek girth on
postoperative day 1, day 2, day 5, and day 7. There was
a statistically significant reduction in cheek girth on
postoperative day 5.
Table 4 shows changes in cheek girth in the dexamethasone
group. It shows the mean difference in cheek girth on
postoperative day 1, day 2, day 5, and day 7. There was
statistically significant reduction in cheek girth on postoperative
day 2 and day 5. Figure 3 shows the mean comparative
efficacies of dexamethasone and serratiopeptidase in the
reduction of cheek girth. There was statistically significant
mean difference between the serratiopeptidase group and
dexamethasone group on postoperative day 2 (mean difference
was 4.3 with P < 0.001).
Discussion
Most surgical procedures result in a certain amount of
postoperative edema. The swelling usually reaches its
maximum within 48–72 h, after the surgical procedure. It
begins to subside in the late postoperative phase. The operator
can control the amount of postsurgical edema by performing
surgery in a manner that minimizes the tissue damage. Some
believe that ice applied to freshly wounded areas decreases
the vascularity and thereby decreases transudation. However,
no controlled study has verified this practice.[9]
Glucocorticoids are a group of steroids that possess
anti‑inflammatory properties. Perhaps, one of the most
important actions of corticosteroids is the suppression or
prevention of inflammation by interfering with capillary
dilatation, edema formation, fibrin deposition, leucocyte
migration, and phagocytosis.[10]
Mechanism of the action of
glucocorticoids are due to its effect on movement suppression
and function of leukocytes, accumulation of macrophage at
inflammatory site, and prevention of prostaglandin synthesis
by inhibiting the arachidonic acid cascade. Lipocortin is an
endogenous protein produced by steroids. It blocks the activity
of phospholipaseA2, thus inhibiting the release of arachidonic
acid from cell membranes and the synthesis of prostaglandins,
leukotrienes, and thromboxanes.[11]
During the selection of therapeutic regimen for
glucocorticosteroid administration, a number of decisions must
be made, including the type of steroid, the dosage, the route of
administration, and, finally, the timing of the administration,
related to the surgical procedure. In selecting the steroid, the
major advantage is offered by the synthetic agents in use today
and is the ones with longer duration of action and little or no
mineralocorticoid activity.[12]
Figure 2: Graph showing the facial measurements
[Downloaded free from http://www.amsjournal.com on Monday, June 8, 2020, IP: 123.201.248.82]
4. Krishna, et al.: Serratiopeptidase and dexamethasone in postoperative swelling
Annals of Maxillofacial Surgery ¦ Volume 10 ¦ Issue 1 ¦ January-June 2020 111
In a study on dexamethasone for reduction of swelling
following extraction of the third molar teeth was conducted,
and it was concluded that dexamethasone group had more
patients with mild swelling and fewer patients with severe
swelling.[13]
Another study was conducted for establishing the
anti‑inflammatory effects of dexamethasone. It was concluded
that the dexamethasone group had mean swelling volumes
significantly lesser than the controls.[3]
AstudyconductedbyWareet al.used1 mgdexamethasonebythe
oralrouteofadministration,8th
hourlyfor3 daysbeginningonthe
morningofthesurgery.Lindbergused1 mgoraldexamethasone,
8th
hourly on the day of surgery and on 1st
postoperative day,
1st
dose taken, ½ h before the surgery.They reported a significant
clinical improvement in postoperative swelling.[14]
Quantitative assessment of swelling represents a major
difficulty. Evaluation of facial swelling resulting from surgical
Table 1: Facial measurement (mm) of the serratiopeptidase group
Time of assessment Serratiopeptidase group P*
Mean±SD Difference from preoperative measurement
(baseline)
Percentage increase from preoperative
measurement (baseline)
Preoperative (baseline) 475.6±73.4 ‑ ‑ ‑
Postoperative (day 1) 506.2±71.0 30.6±14.8 6.4 <0.001
Postoperative (day 2) 508.8±70.9 33.2±12.6 7.0 <0.001
Postoperative (day 5) 488.8±71.1 13.2±8.1 2.8 <0.001
Postoperative (day 7) 476.3±72.9 0.7±3.1 0.1 0.11 (NS)
*Paired Student’s t‑test for intragroup comparison. SD: Standard deviation, NS: Not significant
Table 2: Facial measurement (mm) of the dexamethasone group
Time of assessment Dexamethasone group P*
Mean±SD Difference from preoperative measurement
(baseline)
Percentage increase from preoperative
measurement (baseline)
Preoperative (baseline) 431.6±83.7 ‑ ‑ ‑
Postoperative (day 1) 451.3±86.5 19.7±18.8 4.6 <0.001
Postoperative (day 2) 446.3±87.4 14.7±20.5 3.4 <0.001
Postoperative (day 5) 437.2±84.7 5.6±16.6 1.3 <0.05
Postoperative (day 7) 430.1±84.4 1.5±14.3 0.3 0.45 (NS)
*Paired Student’s t‑test for intragroup comparison. SD: Standard deviation, NS: Not significant
Table 3: Cheek girth measurement (mm) of the serratiopeptidase group
Time of assessment Serratiopeptidase group P*
Mean±SD Difference from preoperative cheek
girth (baseline)
Percentage increase from preoperative cheek
girth (baseline)
Preoperative (baseline) 29.8±4.3 ‑ ‑ ‑
Postoperative (day 1) 36.2±3.4 6.5±3.6 21.8 <0.001
Postoperative (day 2) 37.4±4.9 7.6±3.7 25.5 <0.001
Postoperative (day 5) 33.2±2.5 3.4±3.0 11.4 <0.001
Postoperative (day 7) 29.7±4.3 0.01±0.05 0.03 0.29 (NS)
*Paired Student’s t‑test. SD: Standard deviation, NS: Not significant
Table 4: Cheek girth measurement (mm) of the dexamethasone group
Time of assessment Dexamethasone group P*
Mean±SD Difference from preoperative cheek
girth (baseline)
Percentage increase from preoperative cheek
girth (baseline)
Preoperative (baseline) 29.6±4.9 ‑ ‑ ‑
Postoperative (day 1) 35.1±5.3 5.4±1.5 18.2 <0.001
Postoperative (day 2) 33.1±4.9 3.4±1.8 11.5 <0.001
Postoperative (day 5) 31.6±4.8 2.0±1.8 6.8 <0.001
Postoperative (day 7) 29.7±4.9 0.1±0.3 0.3 0.18 (NS)
*Paired Student’s t‑test. SD: Standard deviation, NS: Not significant
[Downloaded free from http://www.amsjournal.com on Monday, June 8, 2020, IP: 123.201.248.82]
5. Krishna, et al.: Serratiopeptidase and dexamethasone in postoperative swelling
Annals of Maxillofacial Surgery ¦ Volume 10 ¦ Issue 1 ¦ January-June 2020
112
procedures has proven to be most problematic. Swelling
involves a three‑dimensional volumetric change at the
tissue and cellular level. Methods used to evaluate swelling
include photographic analysis, modified face bow, linear
measurement, subjective assessment, and others.[4,15‑18]
No
technique has been proved to be superior or more accurate in
analyzing swelling. The desire to include a large number of
patients and the practicality of a low‑cost reliable technique
made linear measurement a feasible choice. The swelling was
also measured in terms of cheek girth, using calibrated slide
calipers.
In the present study, the administration of dexamethasone
resulted in significantly less degree of swelling on the
2nd
postoperative day. There was further reduction of
swelling by 7th
postoperative day. The facial size reached
the preoperative. In the present study, the oral route of drug
administration was done. With respect to measurement by
7th
‑day routes of administration, virtually, all avenues of
administration have been used with corticosteroids. However,
onset, peak, and duration of action are dependent on the route
of administration, the dosage, and the solubility of the agent.
With the oral route, corticosteroids are rapidly and almost
completely absorbed; hence, this route of administration is as
effective as parenteral route. All studies using the oral route
of administration reported a clinical reduction in swelling.[12]
In the present study, 1 mg of dexamethasone was given ½ h
before the surgery and continued thrice daily for 3 postoperative
days. The administration of the preoperative dose of
dexamethasone maintains an adequate amount of drug in the
blood before, during, and after the surgery, as dexamethasone
is a long‑acting corticosteroid. Since the appearance of
swelling has been around 4–5 h after surgery, preoperative
administration of the drug would be very effective in preventing
swelling.
Dexamethasone has minimal or zero mineralocorticoid
activity and is a long‑acting corticosteroid with potent
anti‑inflammatory action.[12]
In this study, dexamethasone was
selected as prototype corticosteroid because it is desirable to
use a steroid with minimal mineralocorticoid activity and a
longer duration of action.
Enzymes are extremely potent substances. The possibility
of their therapeutic application is attractive. Enzymes are
derived from bacteria (streptokinase and streptodornase),
plants (papase and bromelain), and animals (trypsin and
chymotrypsin). The enzymes used therapeutically for
reduction of edema are hyaluronidase, streptodornase, trypsin,
chymotrypsin, alpha‑chymotrypsin, and serratiopeptidase.
Various studies have been carried out to determine the
efficacy of serratiopeptidase as an anti‑inflammatory agent.
A prospective study on serratiopeptidase for reduction of
postoperative swelling after upper ankle joint surgery was
conducted, and it was concluded that significant reduction in
swelling was achieved with the use of serratiopeptidase.[19]
Another trial was conducted to investigate the clinical efficacy
of the anti‑inflammatory enzyme preparation, serratiopeptidase
in patients who underwent Caldwell‑Luc‑antrostomy for
chronic empyema and concluded that swelling was smaller
in size in the serratiopeptidase treated group than in the
placebo‑treated group.[20]
Serratiopeptidase was the other drug, which was compared
with dexamethasone for its efficacy to control postoperative
edema. In the present study, administration of 10 mg of
serratiopeptidase, thrice daily for 3 postoperative days resulted
in the reduction of swelling on 5th
postoperative day. The
facial size reached the preoperative facial measurement by
7th
postoperative day.
A study was conducted on prednisolone, a corticosteroid and
papase, an enzyme as inhibitors of complications after the
oral surgery. The conclusion of this study indicated that in
comparing prednisolone and papase, prednisolone was more
effective in reducing postsurgical sequel of trismus and pain,
but no difference was found with regard to edema. This was
probably because few moderate‑to‑severe cases of edema were
observed in the first few postoperative days.[15]
In our study, on comparison between serratiopeptidase and
dexamethasone, it was found that the swelling was less in the
dexamethasone group on postoperative day 1, day 2, and day 5
compared to the serratiopeptidase group on day 1, day 2, and day
5. There was no difference in postoperative swelling on 7th
day
between dexamethasone and serratiopeptidase group. However,
more studies need to be conducted prospectively with a large
samplesizewithmorevariablescomparingitwithacontrolgroup.
Conclusion
Two different classes of drugs, serratiopeptidase, a proteolytic
enzyme having anti‑inflammatory action, and dexamethasone,
a long‑acting corticosteroid with minimum or zero
mineralocorticoid activity having maximum anti‑inflammatory
action, were evaluated for its efficacy and compared with each
other for its ability to reduce the postoperative swelling.
It appeared in this study that both serratiopeptidase and
dexamethasone were effective in the reduction of swelling
but in comparison with serratiopeptidase, dexamethasone was
more effective in the reduction of swelling.
Declaration of patient consent
The authors certify that they have obtained all appropriate
patient consent forms. In the form the patients have given their
consent for their images and other clinical information to be
reported in the journal.The patients understand that their names
and initials will not be published and due efforts will be made
to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
[Downloaded free from http://www.amsjournal.com on Monday, June 8, 2020, IP: 123.201.248.82]
6. Krishna, et al.: Serratiopeptidase and dexamethasone in postoperative swelling
Annals of Maxillofacial Surgery ¦ Volume 10 ¦ Issue 1 ¦ January-June 2020 113
References
1. Alexander RE, Throndson RR. A review of perioperative corticosteroid
use in dentoalveolar surgery. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod 2000;90:406‑15.
2. Baxendale BR, Vater M, Lavery KM. Dexamethasone reduces pain
and swelling following extraction of third molar teeth. Anaesthesia
1993;48:961‑4.
3. Esch PM, Gerngross H, Fabian A. Reduction of postoperative
swelling. Objective measurement of swelling of the upper ankle
joint in treatment with serrapeptase – A prospective study. Fortschr
Med 1989;107:67‑8, 71‑2.
4. Beirne OR, Hollander B. The effect of methylprednisolone on pain,
trismus, and swelling after removal of third molars. Oral Surg Oral Med
Oral Pathol 1986;61:134‑8.
5. Breytenvach HS. Objective measurement of postoperative swelling. Int
J Oral Surg 1979;7:386.
6. Cameron IW. An investigation into some of the factors concerned in
the surgical removal of the impacted lower wisdom tooth, including a
double blind trial of chymoral. Br J Oral Surg 1980;18:112‑24.
7. Edilby GI, Gennit SP. A double blind placebo controlled trial on the
effect of dexamethasone on post operative swelling. J Dent Res
1982;62:556.
8. Caci F, Gluck GM. Double‑blind study of prednisolone and papase
as inhibitors of complications after oral surgery. J Am Dent Assoc
1976;93:325‑7.
9. ElHag M, Coghlan K, Christmas P, Harvey W, Harris M. The
anti‑inflammatory effects of dexamethasone and therapeutic ultrasound
in oral surgery. Br J Oral Maxillofac Surg 1985;23:17‑23.
10. Flower RJ, Blackwell GJ. Anti‑inflammatory steroids induce
biosynthesis of a phospholipase A2 inhibitor which prevents
prostaglandin generation. Nature 1979;278:456‑9.
11. Gilman AG, Rall TW, Nies AS. The Pharmacological Basis of
Therapeutics. New York: Macmillan; 1990. p. 1436.
12. Holland CS. The development of a method of assessing swelling
following third molar surgery. Br J Oral Surg 1979;17:104‑14.
13. Linenberg W. The clinical evaluation of dexamethasone in oral surgery.
Oral Surg Oral Med Oral Pathol 1965;20:6.
14. Milles M, Desjardins PJ, Pawel HE. The facial plethysmograph: A new
instrument to measure facial swelling volumetrically. J Oral Maxillofac
Surg 1985;43:346‑52.
15. Montgomery MT, Hogg JP, Roberts DL, Redding SW. The use of
glucocorticosteroids to lessen the inflammatory sequelae following third
molar surgery. J Oral Maxillofac Surg 1990;48:179‑87.
16. Neupert EA 3rd
, Lee JW, Philput CB, Gordon JR. Evaluation of
dexamethasone for reduction of postsurgical sequelae of third molar
removal. J Oral Maxillofac Surg 1992;50:1177‑82.
17. Peterson LJ, Ellis E 3rd
, Hupp JR, Tucker MR. Contemporary Oral and
Maxillofacial Surgery. St. Louis: Mosby; 2003. p. 47.
18. Satoskar RS, Bhandarkar SD, Ainapure SS. Pharmacology and
Pharmacotherapeutics. Mumbai: Popular Prakashan Private Limited;
2003. p. 1048‑50.
19. Tachibana M, Mizukoshi O, Harada Y, Kawamoto K, Nakai Y.
A multi‑centre, double‑blind study of serrapeptase versus
placebo in post‑antrotomy buccal swelling. Pharmatherapeutica
1984;3:526‑30.
20. Tripathi KD. Essentials of Medical Pharmacology. New Delhi: Jaypee
Brothers Medical Publishers (p) Ltd; 2003. p. 261.
[Downloaded free from http://www.amsjournal.com on Monday, June 8, 2020, IP: 123.201.248.82]